IMS 4112 and VLP of HBV as Th1 Adjuvants for a Recombinant Protein of HIV-1
Open Access
- 17 December 2016
- journal article
- Published by Peertechz Publications Private Limited in Journal of Vaccines and Immunology
- Vol. 2 (1), 026-035
- https://doi.org/10.17352/jvi.000018
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene FamilyJournal of Virology, 2012
- Getting Closer to the Dirty Little SecretImmunity, 2011
- Generation of Humoral Immune Responses to Multi-Allele PfAMA1 Vaccines; Effect of Adjuvant and Number of Component Alleles on the Breadth of ResponsePLOS ONE, 2010
- Anti-HIV Activity in Cervical-Vaginal Secretions from HIV-Positive and -Negative Women Correlate with Innate Antimicrobial Levels and IgG AntibodiesPLOS ONE, 2010
- Mucosal Immunity and Protection Against HIV/SIV Infection: Strategies and Challenges for Vaccine DesignInternational Reviews of Immunology, 2009
- Expression of Toll-like receptors in cultured nasal epithelial cellsActa Oto-Laryngologica, 2007
- Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor SignalingScience, 2006
- Influence of Aluminum-Based Adjuvant on the Immune Response to Multiantigenic FormulationViral Immunology, 2006
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Mucosal immunogenicity of the hepatitis B core antigenBiochemical and Biophysical Research Communications, 2003